Chandan Taparia of Motilal Oswal Securities has a buy call on Dr.
Reddy's Laboratories Ltd.
with a target price of Rs 3160.0 .
The current price of Dr.
Reddy's Laboratories Ltd.
is Rs 3058.0 Time period given by the analyst is Intra Day when Dr.
Reddy's Laboratories Ltd.
price can reach defined target.Chandan Taparia recommended to keep a stoploss at Rs 3010 .
Dr.
Reddy's Laboratories Ltd., incorporated in 1984, has a market cap of Rs 50812.69 crore.Dr.
Reddy's Laboratories Ltd.
key Products/Revenue Segments include Pharmaceuticals which contributed Rs 10466.70 Crore to Sales Value (98.50 % of Total Sales), Licence Fees which contributed Rs 55.90 Crore to Sales Value (0.52 % of Total Sales), Service Income which contributed Rs 50.30 Crore to Sales Value (0.47 % of Total Sales), Spent Chemicals which contributed Rs 35.60 Crore to Sales Value (0.33 % of Total Sales), Scrap which contributed Rs 16.10 Crore to Sales Value (0.15 % of Total Sales) and Other Operating Revenue which contributed Rs .90 Crore to Sales Value (0.00 % of Total Sales)for the year ending 31-Mar-2019.
For the quarter ended 30-09-2019, the company has reported a Consolidated sales of Rs 4800.80 Crore, up 24.90 % from last quarter Sales of Rs 3843.60 Crore and up 30.22 % from last year same quarter Sales of Rs 3686.60 Crore Company has reported net profit after tax of Rs 1095.10 Crore in latest quarter.
The companys top management includes Dr.Bruce L A Carter, Mr.Allan Oberman, Mr.Bharat N Doshi, Mr.G V Prasad, Mr.K Satish Reddy, Mr.Leo Puri, Mr.Prasad R Menon, Mr.Sridar Iyengar, Ms.Kalpana Morparia, Ms.Shikha Sharma.
Company has S R Batliboi - Associates LLP as its auditors.
As on 31-12-2019, the company has a total of 166,163,148 shares outstanding.